These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 12023281)

  • 1. Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration.
    Macias-Silva M; Li W; Leu JI; Crissey MA; Taub R
    J Biol Chem; 2002 Aug; 277(32):28483-90. PubMed ID: 12023281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins.
    He J; Tegen SB; Krawitz AR; Martin GS; Luo K
    J Biol Chem; 2003 Aug; 278(33):30540-7. PubMed ID: 12764135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of c-myc repression coincides with ovarian cancer resistance to transforming growth factor beta growth arrest independent of transforming growth factor beta/Smad signaling.
    Baldwin RL; Tran H; Karlan BY
    Cancer Res; 2003 Mar; 63(6):1413-9. PubMed ID: 12649207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel regulation of Ski protein stability and endosomal sorting by actin cytoskeleton dynamics in hepatocytes.
    Vázquez-Victorio G; Caligaris C; Del Valle-Espinosa E; Sosa-Garrocho M; González-Arenas NR; Reyes-Cruz G; Briones-Orta MA; Macías-Silva M
    J Biol Chem; 2015 Feb; 290(7):4487-99. PubMed ID: 25561741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of Smad transcriptional corepressors SnoN and Ski in the fibrotic kidney: an amplification mechanism for TGF-beta1 signaling.
    Yang J; Zhang X; Li Y; Liu Y
    J Am Soc Nephrol; 2003 Dec; 14(12):3167-77. PubMed ID: 14638915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The oncoprotein Ski acts as an antagonist of transforming growth factor-beta signaling by suppressing Smad2 phosphorylation.
    Prunier C; Pessah M; Ferrand N; Seo SR; Howe P; Atfi A
    J Biol Chem; 2003 Jul; 278(28):26249-57. PubMed ID: 12732634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Actin-cytoskeleton polymerization differentially controls the stability of Ski and SnoN co-repressors in normal but not in transformed hepatocytes.
    Caligaris C; Vázquez-Victorio G; Sosa-Garrocho M; Ríos-López DG; Marín-Hernández A; Macías-Silva M
    Biochim Biophys Acta; 2015 Sep; 1850(9):1832-41. PubMed ID: 26002202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NEDD4-2 (neural precursor cell expressed, developmentally down-regulated 4-2) negatively regulates TGF-beta (transforming growth factor-beta) signalling by inducing ubiquitin-mediated degradation of Smad2 and TGF-beta type I receptor.
    Kuratomi G; Komuro A; Goto K; Shinozaki M; Miyazawa K; Miyazono K; Imamura T
    Biochem J; 2005 Mar; 386(Pt 3):461-70. PubMed ID: 15496141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad3 recruits the anaphase-promoting complex for ubiquitination and degradation of SnoN.
    Stroschein SL; Bonni S; Wrana JL; Luo K
    Genes Dev; 2001 Nov; 15(21):2822-36. PubMed ID: 11691834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic SnoN in normal tissues and nonmalignant cells antagonizes TGF-beta signaling by sequestration of the Smad proteins.
    Krakowski AR; Laboureau J; Mauviel A; Bissell MJ; Luo K
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12437-42. PubMed ID: 16109768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transforming growth factor-β/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4.
    Tecalco-Cruz AC; Sosa-Garrocho M; Vázquez-Victorio G; Ortiz-García L; Domínguez-Hüttinger E; Macías-Silva M
    J Biol Chem; 2012 Aug; 287(32):26764-76. PubMed ID: 22674574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury.
    Fukasawa H; Yamamoto T; Togawa A; Ohashi N; Fujigaki Y; Oda T; Uchida C; Kitagawa K; Hattori T; Suzuki S; Kitagawa M; Hishida A
    Kidney Int; 2006 May; 69(10):1733-40. PubMed ID: 16625151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two short segments of Smad3 are important for specific interaction of Smad3 with c-Ski and SnoN.
    Mizuide M; Hara T; Furuya T; Takeda M; Kusanagi K; Inada Y; Mori M; Imamura T; Miyazawa K; Miyazono K
    J Biol Chem; 2003 Jan; 278(1):531-6. PubMed ID: 12426322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement for the SnoN oncoprotein in transforming growth factor beta-induced oncogenic transformation of fibroblast cells.
    Zhu Q; Pearson-White S; Luo K
    Mol Cell Biol; 2005 Dec; 25(24):10731-44. PubMed ID: 16314499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Ski inhibits the TGF-beta signaling pathway through stabilization of inactive Smad complexes on Smad-binding elements.
    Suzuki H; Yagi K; Kondo M; Kato M; Miyazono K; Miyazawa K
    Oncogene; 2004 Jun; 23(29):5068-76. PubMed ID: 15107821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Jun associates with the oncoprotein Ski and suppresses Smad2 transcriptional activity.
    Pessah M; Marais J; Prunier C; Ferrand N; Lallemand F; Mauviel A; Atfi A
    J Biol Chem; 2002 Aug; 277(32):29094-100. PubMed ID: 12034730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of SnoN oncoprotein induced by antibiotics anisomycin and puromycin positively regulates transforming growth factor-β signals.
    Hernández-Damián J; Tecalco-Cruz AC; Ríos-López DG; Vázquez-Victorio G; Vázquez-Macías A; Caligaris C; Sosa-Garrocho M; Flores-Pérez B; Romero-Avila M; Macías-Silva M
    Biochim Biophys Acta; 2013 Nov; 1830(11):5049-58. PubMed ID: 23872350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient TGF-β/SMAD signaling in human melanoma cells associated with high c-SKI/SnoN expression.
    Javelaud D; van Kempen L; Alexaki VI; Le Scolan E; Luo K; Mauviel A
    Mol Cancer; 2011 Jan; 10(1):2. PubMed ID: 21211030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
    Poncelet AC; de Caestecker MP; Schnaper HW
    Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.